SCOR went into this earnings print with a stock that had already been grinding higher, up about 8.1% over three months, yet still trading on a modest P/E of 7.4x. The market reaction around the numbers now has to weigh that value label against what the quarter actually delivered.

The headline is clear. Q2 2026 showed solid profitability for a reinsurer, with net income of €172m on €4.54b in revenue and a group return on equity near the high teens in the first half. For you as an investor, this result is focused on earnings quality and capital strength rather than sheer top line excitement.

Like the earnings power at SCOR but still wondering which insurers pair solid profitability with balance sheet strength at a reasonable valuation? Take a look at our curated list of list of solid balance sheet and fundamentals stocks (414 results).

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): €4,540m vs. €3,109m (up 46.1%)
• Net Income (Excl. Extra Items, Q2 2026 vs Q2 2025): €172m vs. €225m (down 23.6%)
• Basic EPS (Q2 2026 vs Q2 2025): €0.96 vs. €1.26 (down 23.5%)
• Trailing 12 Month Net Profit Margin (year over year): 4.9% vs. 3.3% (improved margin)

Prefer clean charts instead of another dense page of earnings tables and ratios? See SCOR’s full financial picture, including an at a glance view of its valuation, in the interactive company report for SCOR.

SCOR earnings support quality focused upside story

For a bullish view, SCOR’s recent results lean your way. Revenue of €4,540m with Q2 net income of €172m and group ROE near the high teens in H1 point to a business currently converting underwriting and investment activity into solid profits. The P&C combined ratio around 80% and a solvency ratio at 220% back the idea of a diversified reinsurer that is both profitable and well capitalised. If you like the “global risk partner” narrative, these numbers broadly align with it.

Short term profit swings keep SCOR risk in view

For the cautious view, there is also support. Net income excluding extra items fell from €225m in Q2 2025 to €172m in Q2 2026, with EPS moving the same way. Life & Health still carries arbitration noise and a U shaped recovery profile, which shows that complexity is not just theoretical. Management highlights competitive renewals and pending arbitration as ongoing watchpoints. Even with a 4.9% trailing net margin and strong capital, these results remind you that SCOR’s earnings path can remain uneven.

After a quarter where SCOR’s profits moved around and dividends already show an unstable track record, it is reasonable to ask whether these are isolated noise or signs of deeper structural weakness. Review our independent risk analysis for SCOR which shows 1 important warning sign

Stay Ahead With Simply Wall St

If SCOR’s mix of solid profitability, uneven quarterly earnings and modest P/E makes you want to watch for a better balance between price and fundamentals, register for free with Simply Wall St and add it to your Watchlist to track share price against fair value for a potential entry point. Once you are invested, use the Portfolio Command Center to keep your holdings organised and surface only the most important updates that cut through short term noise. For a longer term view, plug into the Community to see how other investors are interpreting the same data and key events. This way you can spot potential catalysts or emerging risks early and stay a step ahead of the market.

Seeking Fresh Alternatives Beyond SCOR?

Some stocks are building quiet breakout momentum while others risk being caught dropping before the crowd even looks. Scan these fresh ideas while it matters and act now.

• Spot income workhorses that could help keep portfolios grounded while prices are still under the radar using our curated 432 dividend fortresses.
• Track future facing chip and hardware plays linked to AI infrastructure momentum through a focused list of 56 AI infrastructure stocks.
• Hunt for overlooked compounders with resilient balance sheets and improving cash generation inside our carefully filtered 524 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.